Note H - Segment Information (Tables)

3 Months Ended

Sep. 30, 2025

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

									Natural
						Corporate			Alternatives
	Private-label			Patent and		expenses			International
	contract			trademark		not allocated			Inc.
	manufacturing			licensing		to segments			Consolidated
Net sales	$	36,065		$	1,665	$	-		$	37,730
Cost of goods sold		32,909			424		-			33,333
Gross profit		3,156			1,241		-			4,397
Selling, general and administrative expenses		1,353			529		2,231			4,113
Income (loss) from operations		1,803			712		(2,231	)		284
Other income (expense):
Interest income		30			-		-			30
Interest expense		(226	)		-		-			(226	)
Foreign exchange loss		(301	)		-		-			(301	)
Other, net		14			-		-			14
Total other expense		(483	)		-		-			(483	)
Income (loss) before income taxes		1,320			712		(2,231	)		(199	)
Provision for income taxes										92
Net loss									$	(291	)
Other supplemental information:
Stock-based compensation	$	162		$	15	$	-		$	177
Depreciation and amortization		1,164			2		-			1,166
Capital expenditures		1,030			-		-			1,030

									Natural
						Corporate			Alternatives
	Private-label			Patent and		expenses			International
	contract			trademark		not allocated			Inc.
	manufacturing			licensing		to segments			Consolidated
Net sales	$	30,630		$	2,520	$	-		$	33,150
Cost of goods sold		30,001			890		-			30,891
Gross profit		629			1,630		-			2,259
Selling, general and administrative expenses		1,274			633		2,188			4,095
(Loss) income from operations		(645	)		997		(2,188	)		(1,836	)
Other income (expense):
Interest income		33			-		-			33
Interest expense		(178	)		-		-			(178	)
Foreign exchange loss		(431	)		-		-			(431	)
Other, net		(1	)		-		-			(1	)
Total other expense		(577	)		-		-			(577	)
(Loss) income before income taxes		(1,222	)		997		(2,188	)		(2,413	)
Benefit for income taxes										(431	)
Net loss									$	(1,982	)
Other supplemental information:
Stock-based compensation	$	251		$	25	$	—		$	276
Depreciation and amortization		1,125			2		-			1,127
Capital expenditures		301			-		-			301

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	September 30, 2025		June 30, 2025
Private-label contract manufacturing	$	118,144	$	113,843
Patent and trademark licensing		38,801		38,096
Total Assets	$	156,945	$	151,939